Company / Capital Returned to Shareholders
MEDIFAST INC Capital Returned to Shareholders History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$195.0K
FY2025
5-year range
$195.0K / $76.6M
FY2021-FY2025
Trend
-72.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $195,000 in FY2025 to $77M in FY2023.
Based on SEC 10-K filings.
$195,000 in FY2025 with a 10-year CAGR of -37.1%.
Declined from $77M to $195,000 over the past 2 years.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -67.4%
- 10-Year CAGR
- -37.1%
Key checks
Key Insights
- 5-year CAGR of -67.4%, indicating a declining trend.
- In FY2025, capital returned to shareholders decreased 72.7% year-over-year.
- Peak capital returned to shareholders was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $195.0K | -72.7% |
| FY2024 | $715.0K | -99.1% |
| FY2023 | $76.6M | +44.1% |
| FY2020 | $53.2M | +17.1% |
| FY2019 | $45.4M | +8.4% |
| FY2018 | $41.9M | +86.9% |
| FY2017 | $22.4M | -51.1% |
| FY2016 | $45.8M | +128.0% |
| FY2015 | $20.1M | +626.5% |
| FY2014 | $2.8M | -86.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026